News ArchivesRead News
Imaging Biomarker Proposed for Parkinson’s Disease
Thursday July 10, 2014
Medwire News - Reduced off-medication connectivity in the basal ganglia network (BGN) separates patients with early Parkinson’s disease (PD) from healthy controls with high accuracy, preliminary findings suggest.
Furthermore, the differences in BGN connectivity disappeared when the PD patients in the study were taking dopaminergic medication.
“This finding suggests that reduced connectivity in the BGN is a functional rather than structural phenomenon and is related to PD-specific dopamine-dependent processes”, write senior study authors Michele Hu and Clare Mackay, from the University of Oxford in the UK, and team in Neurology.
The researchers created a BGN template using an observer-independent technique on data from 80 healthy elderly controls who underwent resting-state functional magnetic resonance imaging (RS-fMRI). They then created BGN connectivity maps of 19 PD patients and 19 age- and gender-matched healthy controls.
The PD patients had been diagnosed within the past 3 years and were taking medication. When scanned 12 to 17 hours after medication withdrawal these patients had significantly reduced connectivity relative to controls in nine clusters across the BGN: the putamen and caudate bilaterally, midbrain, superior temporal gyrus bilaterally, dorsolateral prefrontal cortex bilaterally, medial prefrontal cortex, and precuneus.
BGN connectivity significantly increased in the patients when they were scanned on medication, abolishing the differences relative to the controls.
The average connectivity parameter estimates (PE) value for the significantly different clusters was 1.04 in the PD patients versus 7.59 in controls. In a post-hoc analysis, a PE value of 3.88 distinguished between patients and controls with 100% sensitivity and 89.5% specificity.
The researchers applied this cutoff to a validation cohort of 13 PD patients, including five drug-naïve patients, and it classified these individuals with 85% accuracy (two were misclassified). It correctly classified four of the five drug-naïve patients, which the team says increases the “robustness of the finding and speaks against it being a simple effect of short-term medication withdrawal.”
BGN connectivity was not associated with clinical measures of PD symptom severity, which the team says may mean that it “is a trait marker of disease, reflecting a constitutional fault of the network and not the resulting clinical symptoms.”
In an editorial accompanying the study, Nicolaas Bohnen (University of Michigan, Ann Arbor, USA) and WR Wayne Martin (University of Alberta, Edmonton, Canada) say: “Although clinical translation of RS-fMRI to real-world neurology practice will need to clear many more hurdles, this proof-of-concept study offers great promise for the future.
“It demonstrates the potential for a functional and dopaminergic medication-responsive MRI technique to characterize disease-specific brain networks that can be quantitatively expressed and provide a reader-independent diagnosis.”
McDermid, Eleanor. (10 July 2014). Medwire News. Imaging Biomarker Proposed for Parkinson’s Disease. http://www.medwirenews.com/454/105718/Parkinsons_disease/Imaging_biomarker_proposed_for_Parkinsons_disease.html
Recent NewsSep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 9 - Parkinson’s Experiment to Be Aboard Next Flight to International Space Station
Aug 9 - Parkinson’s Disease and Sleeping with the Enemy
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement